Προηγούμενες/Αποτελέσματα
Προηγούμενες/Αποτελέσματα
Προηγούμενες/Αποτελέσματα
This page provides the list of testing proposal consultations for which the deadline for comments has passed. ECHA addresses all third-party contributions in the dossier evaluation decisions addressed to the registrant.
To see if testing proposals submitted by registrants, and for which ECHA has held a third-party consultation, were subsequently withdrawn, please consult the table below. First, follow the link to the related aggregated registration dossier (if it is already published). There you can review the details of the testing proposed and other information on the substance that is subject to the testing proposal. The admissibility of any testing proposal will be concluded only after the third party consultation. Later during the testing proposal examination process, you may check the same section in the disseminated dossier to see if a testing proposal previously present has been withdrawn. The reasons for withdrawal may be that the registrant has reviewed their assessment or has taken into account the third-party comments provided to ECHA and communicated to them.
1,2,4,5,7,8-Hexoxonane, 3,6,9-trimethyl-, 3,6,9-tris(Ethyl and Propyl) derivatives | - | - | Sub-chronic toxicity (90-day): oral | 30/06/2016 | 15/08/2016 | Details | |
3,5-bis(2,4-dimethylcyclohex-3-en-1-yl)polyheterocycle | - | - | Genetic toxicity in vivo | 16/03/2015 | 30/04/2015 | Details | |
3-[(diisoalkyloxyphosphorothioyl)thio]-2-methylalkanoic acid | - | - | Developmental toxicity (pre-natal developmental toxicity) | 15/03/2011 | 29/04/2011 | Details | |
Addition products of m-phenylenebis(methylamine) with reaction mass of 2-(2-(2-butoxyethoxy)ethoxy)ethyl 5-isocyanato-2-methylphenylcarbamate, 2-(2-(2-butoxyethoxy)ethoxy)ethyl 3-isocyanato-4-methylphenylcarbamate and 2-(2-(2-butoxyethoxy)ethoxy)ethyl 3-isocyanato-2-methylphenylcarbamate | - | - |
Reproductive toxicity (pre-natal developmental toxicity) Reproductive toxicity (two-generation reproductive toxicity) || Note: Testing proposal is based on potential concern identified by the registrant. Sub-chronic toxicity (90 day): oral |
15/07/2014 15/07/2014 15/07/2014 |
29/08/2014 29/08/2014 29/08/2014 |
Details | |
Alkenes, C13-14 | - | - |
Reproductive toxicity (pre-natal developmental toxicity) Reproductive toxicity (two-generation reproductive toxicity) |
29/07/2011 29/07/2011 |
12/09/2011 12/09/2011 |
Details | |
Alkenes, C13-14, hydroformylation products, low boiling | - | - | Reproductive toxicity (two-generation reproductive toxicity) | 29/07/2011 | 12/09/2011 | Details | |
Alkenes, C6-8, even and odd, linear and branched | - | - | Sub-chronic toxicity (90-day): oral | 25/06/2012 | 09/08/2012 | Details | |
Alkenes, C6-8, even and odd, linear and branched | - | - |
Reproductive toxicity (pre-natal developmental toxicity) Reproductive toxicity (two-generation reproductive toxicity) |
29/07/2011 29/07/2011 |
12/09/2011 12/09/2011 |
Details | |
alkoxy substituted aryl diazo heterocyclic aryl nitrile | - | - | Genetic toxicity in vivo | 31/01/2023 | 17/03/2023 | Details | |
alkyl amine and alkylbenzenesulphonate | - | - |
Reproductive toxicity (pre-natal developmental toxicity) Sub-chronic toxicity (90-day): oral |
26/03/2018 26/03/2018 |
11/05/2018 11/05/2018 |
Details | |